Amid federal grant turmoil, a CT vaccine startup keeps its focus on preventing a deadly disease
The state's bioscience sector continues to grow even as federal funding interruptions poses a threat. |!| Torrington
The state's bioscience sector continues to grow even as federal funding interruptions poses a threat. |!| Torrington